Top compounds associated with response to SLC2A3


Feature Type Standardized
Nominal ANOVA
mRNA alvocidib CTRPv2 pan-cancer AAC 0.01 0.8
mRNA CIL55A CTRPv2 pan-cancer AAC 0.0098 0.8
mRNA tivantinib CTRPv2 pan-cancer AAC 0.009 0.8
mRNA AEW541 CCLE pan-cancer AAC -0.009 0.8
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0063 0.8
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC 0.01 0.8
mRNA methylstat CTRPv2 pan-cancer AAC 0.008 0.8
mRNA Bryostatin 1 FIMM pan-cancer AAC -0.034 0.9
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0071 0.9
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.0066 0.9
Download CSV